Noleus Selected for VentureWell's ASPIRE Life Science Program
- swarna0
- Feb 8, 2018
- 1 min read
Noleus Technologies was selected to attend VentureWell's ASPIRE Life Science program in February 2018. The team will travel to New Orleans for a week to focus on preparations for opening a funding round and networking with other life science startups.
VentureWell "works directly with a variety of early stage innovators to help them bring their ideas to market through workshops and training, coaching and mentoring, funding and awards." Their partners include the NSF, Lemelson Foundation, Ewing Marion Kauffman Foundation, and more. Further information can be found at venturewell.org.
Noleus Technologies is developing a medical device designed to accelerate patient recovery following abdominal surgery. The Noleus device mitigates post-operative bowel swelling, speeding patient recovery. Noleus Technologies, Inc. is a privately held company in Houston, TX.
Recent Posts
See AllSwarna Balasubramaniam, MD, spoke at last night's MDG Boston event "MedTech Leaders Share Insights from Product Development Journeys",...
Noleus applied for the competitive StartX Med process to work alongside entrepreneurs in the StartX program, which is focused on...
Noleus has one another grand prize, this time at the Walleye Tank Pitch Competition presented by Mayo Rochester. The Walley Talk Life...